BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38335758)

  • 1. Design, synthesis, and pharmacological evaluation of novel benzothiazole derivatives targeting LCK in acute lymphoblastic leukemia.
    Chen Y; Zhang K; Tan J; Fan Z; Fu Y; Li X; Liu B; Wang G
    Bioorg Chem; 2024 Mar; 144():107180. PubMed ID: 38335758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre T-cell receptor alpha (pTalpha) expression patterns and functional analysis in human T-cell lymphoblastic leukemia.
    Ivanyi P; Morgan M; Piao W; Ukena SN; Steube K; Ganser A; Franzke A
    Cell Oncol; 2010; 32(1-2):101-8. PubMed ID: 20208138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NUP214-ABL1-mediated cell proliferation in T-cell acute lymphoblastic leukemia is dependent on the LCK kinase and various interacting proteins.
    De Keersmaecker K; Porcu M; Cox L; Girardi T; Vandepoel R; de Beeck JO; Gielen O; Mentens N; Bennett KL; Hantschel O
    Haematologica; 2014 Jan; 99(1):85-93. PubMed ID: 23872305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Lck enhances glucocorticoid sensitivity and apoptosis in lymphoid cell lines and in chronic lymphocytic leukemia.
    Harr MW; Caimi PF; McColl KS; Zhong F; Patel SN; Barr PM; Distelhorst CW
    Cell Death Differ; 2010 Sep; 17(9):1381-91. PubMed ID: 20300113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tyrosine phosphorylation-dependent activation of NF-kappa B. Requirement for p56 LCK and ZAP-70 protein tyrosine kinases.
    Livolsi A; Busuttil V; Imbert V; Abraham RT; Peyron JF
    Eur J Biochem; 2001 Mar; 268(5):1508-15. PubMed ID: 11231305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic targeting of LCK tyrosine kinase and mTOR signaling in T-cell acute lymphoblastic leukemia.
    Laukkanen S; Veloso A; Yan C; Oksa L; Alpert EJ; Do D; Hyvärinen N; McCarthy K; Adhikari A; Yang Q; Iyer S; Garcia SP; Pello A; Ruokoranta T; Moisio S; Adhikari S; Yoder JA; Gallagher K; Whelton L; Allen JR; Jin AH; Loontiens S; Heinäniemi M; Kelliher M; Heckman CA; Lohi O; Langenau DM
    Blood; 2022 Oct; 140(17):1891-1906. PubMed ID: 35544598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for activated Lck protein tyrosine kinase as the driver of proliferation in acute myeloid leukemia cell, CTV-1.
    Li L; Cui Y; Shen J; Dobson H; Sun G
    Leuk Res; 2019 Mar; 78():12-20. PubMed ID: 30660961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of p56(lck) tyrosine kinase by isothiazolones.
    Trevillyan JM; Chiou XG; Ballaron SJ; Tang QM; Buko A; Sheets MP; Smith ML; Putman CB; Wiedeman P; Tu N; Madar D; Smith HT; Gubbins EJ; Warrior UP; Chen YW; Mollison KW; Faltynek CR; Djurić SW
    Arch Biochem Biophys; 1999 Apr; 364(1):19-29. PubMed ID: 10087161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and Characterization of the Amphioxus Lck and Its Associated Tyrosine Phosphorylation-Dependent Inhibitory LRR Receptor.
    Zhou J; Xiao Z; Zhan Y; Qu X; Mou S; Deng C; Zhang T; Lan X; Huang S; Li Y
    Front Immunol; 2021; 12():656366. PubMed ID: 34149695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-targeting of Akt and Myc inhibits viability of lymphoma cells from Lck-Dlx5 mice.
    Tan Y; Sementino E; Pei J; Kadariya Y; Ito TK; Testa JR
    Cancer Biol Ther; 2015; 16(4):580-8. PubMed ID: 25793663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene transfer investigations of p56-LCK function in IL-2-dependent T-cell lines: implications for mechanisms of IL-2-signal transduction.
    Taichman RS; Torigoe T; Tanaka S; Miyashita T; Reed JC
    Cytokine; 1992 Nov; 4(6):441-53. PubMed ID: 1292628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel role for p56/Lck in regulation of endothelial cell survival and angiogenesis.
    Betapudi V; Shukla M; Alluri R; Merkulov S; McCrae KR
    FASEB J; 2016 Oct; 30(10):3515-3526. PubMed ID: 27402674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The anti-apoptotic effect of Notch-1 requires p56lck-dependent, Akt/PKB-mediated signaling in T cells.
    Sade H; Krishna S; Sarin A
    J Biol Chem; 2004 Jan; 279(4):2937-44. PubMed ID: 14583609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical evaluation of proteolytic targeting of LCK as a therapeutic approach in T cell acute lymphoblastic leukemia.
    Hu J; Jarusiewicz J; Du G; Nishiguchi G; Yoshimura S; Panetta JC; Li Z; Min J; Yang L; Chepyala D; Actis M; Reyes N; Smart B; Pui CH; Teachey DT; Rankovic Z; Yang JJ
    Sci Transl Med; 2022 Aug; 14(659):eabo5228. PubMed ID: 36001679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncogenic deubiquitination controls tyrosine kinase signaling and therapy response in acute lymphoblastic leukemia.
    Jin Q; Gutierrez Diaz B; Pieters T; Zhou Y; Narang S; Fijalkwoski I; Borin C; Van Laere J; Payton M; Cho BK; Han C; Sun L; Serafin V; Yacu G; Von Loocke W; Basso G; Veltri G; Dreveny I; Ben-Sahra I; Goo YA; Safgren SL; Tsai YC; Bornhauser B; Suraneni PK; Gaspar-Maia A; Kandela I; Van Vlierberghe P; Crispino JD; Tsirigos A; Ntziachristos P
    Sci Adv; 2022 Dec; 8(49):eabq8437. PubMed ID: 36490346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein kinase C plays a role in the induction of tyrosine phosphorylation of lymphoid microtubule-associated protein-2 kinase. Evidence for a CD3-associated cascade that includes pp56lck and that is defective in HPB-ALL.
    Nel AE; Hanekom C; Hultin L
    J Immunol; 1991 Sep; 147(6):1933-9. PubMed ID: 1716287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targets of p56(lck) activity in immature thymoblasts: stimulation of the Ras/Raf/MAPK pathway.
    Lin K; Abraham KM
    Int Immunol; 1997 Feb; 9(2):291-306. PubMed ID: 9040011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p56Lck tyrosine kinase enhances the assembly of death-inducing signaling complex during Fas-mediated apoptosis.
    Sharif-Askari E; Gaucher D; Halwani R; Ma J; Jao K; Abdallah A; Haddad EK; Sékaly RP
    J Biol Chem; 2007 Dec; 282(49):36048-56. PubMed ID: 17932036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of tyrosine kinase p56/Lck in apoptosis induction by anticancer drugs.
    Gruber C; Henkel M; Budach W; Belka C; Jendrossek V
    Biochem Pharmacol; 2004 May; 67(10):1859-72. PubMed ID: 15130763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tyrosine 192 within the SH2 domain of the Src-protein tyrosine kinase p56
    Kästle M; Merten C; Hartig R; Kaehne T; Liaunardy-Jopeace A; Woessner NM; Schamel WW; James J; Minguet S; Simeoni L; Schraven B
    Cell Commun Signal; 2020 Nov; 18(1):183. PubMed ID: 33225946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.